Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efatutazone with Carboplatin/Paclitaxel in Metastatic NSCLC
NCT00806286Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2008
- Primary completion
- Jan 2012
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 2 trial of efatutazone, sponsored by Daiichi Sankyo Co., Ltd.. Started Dec 2008; status: completed.
02
Drugs
efatutazone
Beyond the preview
Go deeper on NCT00806286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00806286.